Here, we identified IRAK3 as a key inhibitor of TLR2/NFκB-mediated chronic inflammation that is negatively associated with oxidative stress, and obesity-related insulin resistance and metabolic syndrome. Here, NFKB1 is linked to obesity due to melanocortin 4 receptor deficiency.